一个雅努斯的凝海绵与一个凝的纳米颗粒嵌入的表面,用于凝固性血静
Yu Wang1,2, Jie Lin1,2, Hao Fu1,2
1Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education), Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, P.R. China.
ACS applied materials & interfaces
|December 26, 2023
概括
研究人员开发了一种Janus凝海绵 (J-ZGS),使用Zeen纳米颗粒进行有效的血液静止,即使是在凝血病的条件下. 这种基于天然聚合物的材料提供了易于制备和强大的凝血能力.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 血液静止研究 血液静止研究
背景情况:
- 基于天然聚合物的静血材料被广泛使用,但开发新材料,以轻松准备强大的凝血病性静血仍然是一个目标.
- 现有的静血药物可能无法有效地治疗以血液凝固受损为特征的出血障碍.
研究的目的:
- 在正常和凝血病的条件下开发一种新型的Janus凝海绵 (J-ZGS),能够在正常和凝血病的条件下进行强大的血液静止.
- 为了研究J-ZGS的制备过程和血静效果,该药物来自于Zeen纳米粒子和自制的凝海绵.
主要方法:
- 采用抗溶剂方法制备了Zeen纳米颗粒.
- 通过冷干燥凝溶液,创建了一个自制凝海绵 (S-GS).
- 雅努斯凝海绵 (J-ZGS) 是通过将纳米粒子嵌入到S-GS表面来构建的.
- 在体外和体内评估了静血性质,血液兼容性和细胞兼容性.
主要成果:
- 优异的Zeen纳米颗粒在体外表现出优异的静血性质,与Zeen粉末和其他纳米颗粒相比,由于红细胞 (RBC) 和血小板粘附的增强.
- 与S-GS和商业等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等等.
- 在体内动脉损伤模型证实了J-ZGS在依赖凝血和凝血病情景中的杰出静血性能.
结论:
- 开发的Janus凝海绵 (J-ZGS) 提供了一种有效的解决方案,用于依赖凝血和凝血病性血液静止.
- 从天然聚合物基纳米颗粒中轻松制备J-ZGS,为先进的静血材料提供了一个有前途的战略.
- 这种方法可以扩展到为具有挑战性的出血条件创建多功能静血器件.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
01:09Coagulation
6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K